The global burden of tuberculosis mortality in children: a mathematical modelling study

Summary Background Tuberculosis in children is increasingly recognised as an important component of the global tuberculosis burden, with an estimated 1 million cases in 2015. Although younger children are vulnerable to severe forms of tuberculosis disease, no age-disaggregated estimates of paediatric tuberculosis mortality exist, and tuberculosis has never been included in official estimates of under-5 child mortality. We aimed to produce a global mortality burden estimate in children using a complementary approach not dependent on vital registration data. Methods In this mathematical modelling study, we estimated deaths in children younger than 5 years and those aged 5–14 years for 217 countries and territories using a case-fatality-based approach. We used paediatric tuberculosis notification data and HIV and antiretroviral treatment estimates to disaggregate the WHO paediatric tuberculosis incidence estimates by age, HIV, and treatment status. We then applied systematic review evidence on corresponding case-fatality ratios. Findings We estimated that 239 000 (95% uncertainty interval [UI] 194 000–298 000) children younger than 15 years died from tuberculosis worldwide in 2015; 80% (191 000, 95% UI 132 000–257 000) of these deaths were in children younger than 5 years. More than 70% (182 000, 140 000–239 000) of deaths occurred in the WHO southeast Asia and Africa regions. We estimated that 39 000 (17%, 23 000–73 000) paediatric tuberculosis deaths worldwide were in children with HIV infections, with 31 000 (36%, 19 000–59 000) in the WHO Africa region. More than 96% (230 000, 185 000–289 000) of all tuberculosis deaths occurred in children not receiving tuberculosis treatment. Interpretation Tuberculosis is a top ten cause of death in children worldwide and a key omission from previous analyses of under-5 mortality. Almost all these deaths occur in children not on tuberculosis treatment, implying substantial scope to reduce this burden. Funding UNITAID, National Institutes of Health, and National Institute for Health Research.

[1]  Jamie Perin,et al.  Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals , 2016, The Lancet.

[2]  R. Black,et al.  Importance of tuberculosis control to address child survival , 2014, The Lancet.

[3]  Jeremy E. Oakley,et al.  A web-based tool for eliciting probability distributions from experts , 2014, Environ. Model. Softw..

[4]  Marcello Pagano,et al.  Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates , 2014, The Lancet.

[5]  P. Hill,et al.  Compiling mortality statistics from civil registration systems in Viet Nam: the long road ahead. , 2010, Bulletin of the World Health Organization.

[6]  M. Uplekar,et al.  What Can We Learn About the Processes of Regulation of Tuberculosis Medicines from the Experiences of Health Policy and System Actors in India, Tanzania, and Zambia? , 2016, International journal of health policy and management.

[7]  A. Misganaw,et al.  Validity of verbal autopsy method to determine causes of death among adults in the urban setting of Ethiopia , 2012, BMC Medical Research Methodology.

[8]  Shabir A Madhi,et al.  Tuberculosis as a cause or comorbidity of childhood pneumonia in tuberculosis-endemic areas: a systematic review. , 2015, The Lancet. Respiratory medicine.

[9]  R. Kumar,et al.  Estimating mortality using data from civil registration: a cross-sectional study in India , 2015, Bulletin of the World Health Organization.

[10]  C. Sismanidis,et al.  Global burden of drug-resistant tuberculosis in children: a mathematical modelling study. , 2016, The Lancet. Infectious diseases.

[11]  Gonghuan Yang,et al.  Validation of verbal autopsy procedures for adult deaths in China. , 2006, International journal of epidemiology.

[12]  P. Hill,et al.  Closing the Policy-Practice Gap in the Management of Child Contacts of Tuberculosis Cases in Developing Countries , 2011, PLoS medicine.

[13]  A. Harries,et al.  From Where Are Tuberculosis Patients Accessing Treatment in India? Results from a Cross-Sectional Community Based Survey of 30 Districts , 2011, PloS one.

[14]  A. Smith,et al.  Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta–analysis , 2014, BMC Infectious Diseases.

[15]  T. Vos,et al.  Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement , 2016, PLoS medicine.

[16]  D. Enarson,et al.  Estimating tuberculosis burden and case detection in Pakistan. , 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[17]  Alan D. Lopez,et al.  Validity of verbal autopsy procedures for determining cause of death in Tanzania , 2006, Tropical medicine & international health : TM & IH.

[18]  S. Gossart-Walker,et al.  Children and HIV , 2005 .

[19]  F. Cobelens,et al.  Diagnosis and Treatment of Tuberculosis in the Private Sector, Vietnam , 2011, Emerging infectious diseases.

[20]  B. Kampmann,et al.  The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysis , 2017, Thorax.

[21]  M. Kimerling,et al.  Size and Usage Patterns of Private TB Drug Markets in the High Burden Countries , 2011, PloS one.

[22]  H. Jenkins,et al.  Two methods for setting child-focused tuberculosis care targets. , 2016, Public health action.

[23]  Brian G. Williams,et al.  Natural History of Tuberculosis: Duration and Fatality of Untreated Pulmonary Tuberculosis in HIV Negative Patients: A Systematic Review , 2011, PloS one.

[24]  Un Desa Transforming our world : The 2030 Agenda for Sustainable Development , 2016 .

[25]  Helen E Jenkins,et al.  Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis. , 2017, The Lancet. Infectious diseases.

[26]  P. Dodd,et al.  Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study. , 2014, The Lancet. Global health.

[27]  P. Whiting,et al.  Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis. , 2013, Health technology assessment.